Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-23-016709

Director acquired 9,604 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bronstein Ben Director 2023-06-27 Option exercise +9,604 $0.55 $5,301 28,248 D
Derivatives
Bronstein Ben Director 2023-06-27 Option exercise · Stock Option (Right to Buy) +9,604 0 D
Loading xslF345X04/doc4.xml…